Filtered By:
Specialty: Cancer & Oncology
Condition: Hypertension

This page shows you your search results in order of date. This is page number 6.

Order by Relevance | Date

Total 198 results found since Jan 2013.

In Patients with Acute Ischemic Stroke and Cancer: The Shorter Interval, the Higher D-Dimer
CONCLUSION: In conclusion, in patients with ischemic stroke and cancer, patients with short interval time between the diagnosis of ischemic stroke and cancer had higher D-dimer than patients with long interval time.PMID:35901344 | DOI:10.31557/APJCP.2022.23.7.2375
Source: Asian Pacific Journal of Cancer Prevention - July 28, 2022 Category: Cancer & Oncology Authors: Xin-Kun Wang Min-Hang Zhou Source Type: research

Socioeconomic inequalities in prevalence, awareness, treatment and control of hypertension: evidence from the PERSIAN cohort study
CONCLUSION: The prevalence of HTN was higher among low-SES individuals, who also showed higher levels of awareness. However, treatment and control of HTN were more concentrated among those who had higher levels of SES, indicating that people at a higher risk of adverse event related to HTN (the low SES individuals) are not benefiting from the advantage of treatment and control of HTN. Such a gap between diagnosis (prevalence) and control (treatment and control) of HTN needs to be addressed by public health policymakers.PMID:35864469 | DOI:10.1186/s12889-022-13444-x
Source: Cancer Control - July 21, 2022 Category: Cancer & Oncology Authors: Mahin Amini Mahdi Moradinazar Fatemeh Rajati Moslem Soofi Sadaf G Sepanlou Hossein Poustchi Sareh Eghtesad Mahmood Moosazadeh Javad Harooni Javad Aghazadeh-Attari Majid Fallahi Mohammad Reza Fattahi Alireza Ansari-Moghaddam Farhad Moradpour Azim Nejatizad Source Type: research

Late effects of childhood cancer recorded at a single outpatient clinic over the course of one year: implications for the follow-up care
Neoplasma. 2022 Jul 13:220531N584. doi: 10.4149/neo_2022_220531N584. Online ahead of print.ABSTRACTSystematic registration and analysis of detailed treatment data and data on late effects in survivors of childhood cancer are important both for building the evidence base for future assessment of current innovative therapies in pediatric oncology and for personalization of preventive care for survivors of childhood cancer. The paper provides a descriptive analysis of medical data (diagnosis, treatment, late effects, and health status) and selected patient-reported outcomes (mental health and psychosocial well-being) from a s...
Source: Neoplasma - July 12, 2022 Category: Cancer & Oncology Authors: Tomas Kepak Hana Hrstkova Vitezslav Dusek Marta Holikova Lucie Strublova Katerina Kepakova Source Type: research